Compare IDEXX Laboratories, Inc. (IDXX) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs iShares 1 3 Year Treasury Bond ETF — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 4,077,691). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| IDXX | SHY | |
|---|---|---|
Market Cap | $40.43B | $26.68B |
Volume | 692,164 | 4,077,691 |
Sector | Health | Fixed Income |
52-Week High | $766.68 | $83.18 |
52-Week Low | $504.70 | $81.05 |
Typical Hold Time | 46 Days | 63 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
SHY trades at $81.20 with minimal daily movement (+0.05%), showing stability amid broader bond market volatility. Technical indicators signal a bearish trend with moving averages pointing downward, though oscillators remain neutral. Recent dividend payments of $0.24-$0.25 per share provide consistent income, but key financial ratios are unavailable for fundamental assessment. The ETF faces headwinds from rising Treasury yields and persistent inflation pressures affecting fixed income markets.
Outlook remains cautious as SHY navigates a challenging interest rate environment. The fund benefits from short-duration focus during Fed tightening cycles but faces pressure from bond market selloffs. Investment opportunity lies in yield advantage over cash, while risks include further rate hikes and prolonged inflation. Institutional sentiment appears mixed given conflicting technical signals and macroeconomic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
